Live Now! Discussing the Impact of WHO Recognition on Indonesia's Healthcare Industry

Jakarta, CNBC Indonesia - Indonesia’s Food and Drug Supervisory Agency (BPOM) has received recognition from the world health authority, obtaining WHO Listed Authority (WLA) status for the regulation of medical products, particularly vaccines. This was announced late last year and places BPOM on par with leading global regulatory authorities.

This achievement carries strategic implications for Indonesia, ranging from strengthening the national pharmaceutical industry, boosting exports, enhancing healthcare supply chain resilience, to improving Indonesia’s reputation in global health diplomacy.

To comprehensively examine the impact of WHO recognition, CNBC Indonesia is hosting a Health Forum with the theme “BPOM Achieves WLA Status, What Are the Benefits for Business Operators?”. The forum will be held on Friday, 27 February 2026, from 15.00 to 17.00 WIB.

The Health Forum will feature speakers from various stakeholder groups, including Taruna Ikrar - Head of BPOM, Deputy for Drug, Narcotics, Precursor and Addictive Substances Supervision - William Adi Teja, Director General of Bio Farma - Shadiq Akasya, and CEO of Biotis Pharmaceuticals - FX Sudirman.

Watch LIVE! on CNBC Indonesia TV and cnbcindonesia.com